Jiangsu Simcere Pharmaceutical Co., Ltd.

This study is testing whether adding a drug called Endostar to standard cisplatin treatment works better than cisplatin alone for controlling malignant pleural effusion or ascites—painful fluid buildup in the chest or abdomen caused by cancer. It involves about 290 adults with ca…